The detection of anti-β2GP1 antibodies in healthy individuals [3,4], APS, and SLE patients without complications [83] indicates that the antibody alone is insufficient for the pathogenesis of APS. The gene discussed is APOH; the disease is autoimmune polyendocrinopathy.